MIF

MIF 분자 정보

영어 이름Macrophage migration inhibitory factor시판 약물 수1
임상 약물 수3표적 별명EC:5.3.2.1,GIF,EC 5.3.3.12,EC 5.3.2.1,Macrophage Migration-Inhibitory Factors,Epididymis Secretory Sperm Binding Protein,EC:5.3.3.12,Phenylpyruvate Tautomerase,L-Dopachrome Tautomerase,MMIF,Glycosylation-inhibiting factor,L-dopachrome isomerase,MIF,Macrophage Migration Inhibitory Factor,Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor),GLIF
최고 연구 개발 단계Approved
영어 이름Macrophage migration inhibitory factor
표적 별명EC:5.3.2.1,GIF,EC 5.3.3.12,EC 5.3.2.1,Macrophage Migration-Inhibitory Factors,Epididymis Secretory Sperm Binding Protein,EC:5.3.3.12,Phenylpyruvate Tautomerase,L-Dopachrome Tautomerase,MMIF,Glycosylation-inhibiting factor,L-dopachrome isomerase,MIF,Macrophage Migration Inhibitory Factor,Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor),GLIF
시판 약물 수1
임상 약물 수3
최고 연구 개발 단계Approved

MIF 제품 목록

  • 속성

    Protein (1)

  • 제품 라이브러리

    온라인 (1)

  • Human (1)

  • 태그

    His Tag & Avi Tag (1)

  • 마커

    Biotin-labeled (1)

제품 번호발현 시스템제품 설명단백질 구조순도특성
MIF-H82E7
Human
HEK293
Biotinylated Human MIF Protein, His,Avitag™
총 수량1
  • 1

MIF분자 배경

Macrophage migration inhibitory factor(MIF) is also known as Glycosylation-inhibiting factor(GIF), L-dopachrome isomerase, L-dopachrome tautomerase, Phenylpyruvate tautomerase. Interacts with CXCR2 extracellular domain, CD74 extracellular domain, COPS5 and BNIPL. The expression of MIF at sites of inflammation suggests a role as mediator in regulating the function of macrophages in host defense. Counteracts the anti-inflammatory activity of glucocorticoids. Has phenylpyruvate tautomerase and dopachrome tautomerase activity (in vitro), but the physiological substrate is not known. It is not clear whether the tautomerase activity has any physiological relevance, and whether it is important for cytokine activity.

MIF분자 별명

MIF,GLIF,MMIF,GIF

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
IPG-1094IPG-1094; IPG-001Phase 2 ClinicalNanjing Immunophage Biotech Co LtdBrain metastases; Brain Neoplasms; Hematologic Neoplasms; Lupus Nephritis; Multiple Myeloma; Multiple Sclerosis; Psoriasis; Solid tumours
상세
TRP2-electroporated autologous dendritic cell therapy (Memorial Sloan-Kettering)Phase 1 ClinicalMemorial Sloan Kettering Cancer CenterMelanoma
상세
STP-1STP-1; STP1Phase 1 ClinicalStalicla SaAutism Spectrum Disorder
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
IbudilastKC-404; AV-411; MN-166ApprovedKyorin Pharmaceutical Co LtdKetas, Pinatos, EyevinalJapanAsthma; Multiple Sclerosis; NeuralgiaKyorin Pharmaceutical Co LtdAlcoholism; Amyotrophic Lateral Sclerosis; Asthma; Diabetic Neuropathies; Headache Disorders, Secondary; HIV Infections; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Neuralgia; Opioid-Related Disorders; Pneumonia, Viral; Substance-Related Disorders
상세

제품 리뷰

  • S***n2023-04-28
    0사람들이 좋아합니다
    This product was used for characterization of a novel therapeutic testing kinetics and affinity on SPR with a Cytiva BiotinCAPture kit. It worked phenomenally with both the novel approach and a positive control. Additionally, it was used with a Streptavidin coated ELISA plate (also from Acro), results were phenomenal with that approach as well. Overall, this product has been well received by our team and we have already ordered more to continue testing.
  • 분자 정보
  • 제품 목록
  • 시판 약물 정보
  • 제품 리뷰
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호